Unichem gets USFDA nod for Tolterodine Tartrate tablets

Tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

44
USFDA Drug product Approval
USFDA Approval

Last Updated on December 31, 2023 by The Health Master

Unichem Laboratories has received ANDA approval for its Tolterodine Tartrate Tablets, USP 1 mg and 2 mg from the United States Food and Drug Administration (USFDA) to market a generic version of DETROL (tolterodine tartrate) tablets of Pfizer.

Tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

The product will be commercialised from Unichem’s Goa plant.

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.